66568415.pdf

\n\n--- Page 1 ---\n\nGAINESVILLE POLICE DEPARTMENT GENERAL ORDER TITLE ACCREDITATION Nasal Narcan (Naloxone) None PRIOR REVISIONS 10/11/19 PROPONENT UNIT Training and Education Division ATTACHMENT: None NUMBER ISSUE DATE REVISION DATE TOTAL PAGES 40.39 06/28/2022 New 5 I. PURPOSE: The purpose of this policy is to establish guidelines and procedures governing the utilization of intranasal Naloxone administered by the Gainesville Police Department (GPD). The objective is to reduce the number of fatalities which occur as a result of opiate overdose and protect police department employees against accidental exposure of opiates by the proper pre-hospital administration of intranasal Naloxone. II. POLICY: It is the policy of GPD that officers who will be administering Nasal Narcan are properly trained in the use and deployment of the Nasal Narcan as authorized per FSS 381.887 “Emergency Treatment for Suspected Opioid Overdose.” Intranasal Naloxone will be used for the treatment of drug overdose victims. The goal of the responding employee(s) shall be to provide immediate assistance via the use of Naloxone when appropriate, to provide treatment commensurate with their training as first responders, to assist other Emergency Medical Service personnel on scene, and to handle any criminal investigations that may arise. III. DEFINITIONS: • Administer/administration – To introduce an emergency opioid antagonist into the body of a person. • Emergency Opioid Antagonist – Naloxone hydrochloride or any similarly acting drug that blocks the effects of opioids administered from outside the body and that is approved by the United States Food and Drug Administration for the treatment of an opioid overdose. A drug that nullifies in whole or in part the administration of an opioid. The opioid antagonist for the purpose of this policy is limited to naloxone hydrochloride (naloxone). • Medical Control Physician- The Medical Control Physician (MCP) shall be a designated Medical Doctor who is licensed to practice medicine in the State of Florida. GPD shall maintain an affiliation with the MCP. The Chief of Police or his designee shall periodically consult with the MCP to review overall training, equipment, procedures, changes to applicable laws and regulations and/or the review of specific medical cases. At his/her direction, the MCP may assist in training members of GPD. 1\n\n--- Page 2 ---\n\nGAINESVILLE POLICE DEPARTMENT GENERAL ORDER • Naloxone Hydrochloride – A prescription medication used as an emergency opioid antagonist/antidote that blocks the effects of opioids administered from outside the body and is approved by the United States Food and Drug Administration for the treatment of opioid overdose. • Naloxone Nasal Spray – The device issued to trained personnel to administer a prefilled dose of naloxone hydrochloride opioid antagonist via an intranasal mucosal atomization device (nasal spray), in accordance with medical and training protocols. (Brand name: “Nasal Narcan.”) • Opioid(s) – A class of drugs containing or derived from opium. Opioids are medications that relieve pain. They reduce the intensity of pain signals reaching the brain and affect brain areas controlling emotion. Medications that fall within this class include hydrocodone (e.g. Vicodin), oxycodone (e.g. OxyContin, Percocet), morphine, codeine, heroin and related drugs. • Opioid Antagonist- Any drug that binds to an opioid receptor and blocks or inhibits the effects of opioids acting on the receptor, and is approved by the United States Food and Drug Administration for the treatment of an opioid-related drug overdose. • Opioid Overdose – An acute condition due to excessive opioids in the body, manifested by respiratory and/or central nervous system depression. • Patient – A person at risk of experiencing an opioid overdose. • Recovery Position – Lateral, left or right side position. • Universal Precautions- Equipment provided to employees of GPD which may include, but not limited to, nitrile protective gloves, eye protection, respirator masks, and protective suits. IV. PROCEDURE When an employee of GPD arrives at the scene of a medical emergency prior to the arrival of EMS, he/she may reasonably believe a person is suffering from an opiate overdose, which may be indicated by, but not limited to: A. Breathing very slow or not breathing B. Blue or purplish lips or fingernails C. Limp D. Pinpoint Pupils E. Vomiting or gurgling F. Failing to respond If this is the case, employees shall take the following steps prior to, during, and after administering intranasal Naloxone. 2\n\n--- Page 3 ---\n\nGAINESVILLE POLICE DEPARTMENT GENERAL ORDER A. Prior to the assessment of a person, universal precautions should be donned by responding employees. B. Employees should conduct an initial medical assessment of the person to determine if he/she is possibly encountering an opiate overdose based upon his/her scene observations, and/or witness accounts to include statements made by witnesses or family members about drug use. C. If the employee reasonably believes there has been an opiate overdose the Naloxone Nasal Spray should be used. D. The employee shall detain the individual in handcuffs for officer safety and safety of the individual, who could suddenly resuscitate upon application of the Naloxone. This is not required for sworn law enforcement and non-sworn personnel (i.e. PSTs, Property and Evidence personnel) who are accidently exposed while performing in the capacity of their employment with the City of Gainesville. E. A minimum of two officers should be present--if at all possible--for officer safety considerations and patient safety. F. The employee shall pat down the outer layer of clothing of the patient, which does not constitute a search or detainment of the patient. (See F.S.S 893.21- See Below Note) G. The employee shall use the Naloxone Nasal Spray to administer a one (4) milligram intranasal dose of Naloxone to one (1) nostril. H. The employee should observe the individual for 2-3 minutes, and if he/she observes no response, administer a second one (4) milligram intranasal dose of Naloxone to the opposite nostril for a complete dosage of two (4) milligram bottles, (8) milligrams total. I. Employees should be aware that a rapid reversal of an opiate overdose may cause projective vomiting by the person and/or violent behavior. J. The person being treated should continue to be observed and treated as the situation dictates. K. The treating employee shall ensure EMS response, informing them about the treatment and condition of the person. L. The employee shall not relinquish care until relieved by a person with a higher level of training. M. The employee shall contact their supervisor and write an incident report properly documenting the use of Naloxone. N. The supervisor shall forward the incident report to the Nasal Narcan Coordinator. Police canines in the course of their duties may also be exposed to an opiate and experience an overdose. Employees shall take the following steps prior to, during, and after administering Naloxone Nasal Spray to police canines. A. An employee who reasonably believes a police canine is experiencing an overdose should use a Naloxone Nasal Spray. B. The employee shall use the intranasal mist to administer a one (4) milligram intranasal dose of Naloxone to one (1) nostril. C. The employee shall obtain medical treatment for the police canine as soon as possible. 3\n\n--- Page 4 ---\n\nGAINESVILLE POLICE DEPARTMENT GENERAL ORDER NOTE: When an officer deploys Nasal Narcan and it results in a resuscitation of an overdose victim, that officer should ensure that person receives appropriate follow-up care. The effects only last for a limited period of time and the person may experience another opiate overdose when the effects of the Naloxone Nasal Spray wear off. As such, every effort should be made to encourage that person to agree to transport to the hospital for additional